RCM
CTOR

Radcliffe Capital Management’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History

Radcliffe Capital Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-226,721
Closed -$2.48M – 96
2023
Q4 		$2.48M Hold
226,721
– – 0.33% 75
2023
Q3 		$2.44M Hold
226,721
– – 0.3% 115
2023
Q2 		$2.39M Sell
226,721
-19,180
-8% -$202K 0.2% 159
2023
Q1 		$2.55M Buy
+245,901
New +$2.55M 0.16% 199